The Sherwin-Williams Company $SHW Shares Sold by Candriam S.C.A.

Candriam S.C.A. reduced its position in The Sherwin-Williams Company (NYSE:SHWFree Report) by 1.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,695 shares of the specialty chemicals company’s stock after selling 915 shares during the period. Candriam S.C.A.’s holdings in Sherwin-Williams were worth $19,124,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of SHW. Vanguard Group Inc. lifted its position in Sherwin-Williams by 1.1% during the first quarter. Vanguard Group Inc. now owns 22,082,544 shares of the specialty chemicals company’s stock valued at $7,711,004,000 after buying an additional 245,896 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Sherwin-Williams by 21.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,657,536 shares of the specialty chemicals company’s stock valued at $3,023,126,000 after acquiring an additional 1,505,341 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Sherwin-Williams by 1.8% during the 2nd quarter. Geode Capital Management LLC now owns 5,111,157 shares of the specialty chemicals company’s stock valued at $1,746,222,000 after acquiring an additional 90,482 shares in the last quarter. Alliancebernstein L.P. boosted its position in Sherwin-Williams by 2.2% during the 1st quarter. Alliancebernstein L.P. now owns 4,409,209 shares of the specialty chemicals company’s stock worth $1,539,652,000 after purchasing an additional 93,209 shares during the period. Finally, PineStone Asset Management Inc. raised its position in Sherwin-Williams by 12.0% in the second quarter. PineStone Asset Management Inc. now owns 1,681,100 shares of the specialty chemicals company’s stock valued at $577,222,000 after purchasing an additional 180,616 shares during the period. Hedge funds and other institutional investors own 77.67% of the company’s stock.

Sherwin-Williams Trading Down 1.6%

NYSE:SHW opened at $339.10 on Friday. The business’s 50 day moving average is $343.92 and its two-hundred day moving average is $349.12. The Sherwin-Williams Company has a 52 week low of $308.84 and a 52 week high of $400.42. The company has a market cap of $84.06 billion, a PE ratio of 33.08, a P/E/G ratio of 3.26 and a beta of 1.21. The company has a quick ratio of 0.48, a current ratio of 0.82 and a debt-to-equity ratio of 2.11.

Sherwin-Williams (NYSE:SHWGet Free Report) last issued its earnings results on Tuesday, October 28th. The specialty chemicals company reported $3.59 earnings per share for the quarter, topping analysts’ consensus estimates of $3.44 by $0.15. Sherwin-Williams had a net margin of 11.05% and a return on equity of 66.75%. The company had revenue of $6.36 billion for the quarter, compared to analysts’ expectations of $6.21 billion. During the same period in the prior year, the company earned $3.37 earnings per share. The firm’s revenue was up 3.2% compared to the same quarter last year. Sherwin-Williams has set its FY 2025 guidance at 11.250-11.450 EPS. On average, analysts predict that The Sherwin-Williams Company will post 12 EPS for the current year.

Sherwin-Williams Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 14th will be given a dividend of $0.79 per share. This represents a $3.16 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, November 14th. Sherwin-Williams’s dividend payout ratio is presently 30.83%.

Analyst Ratings Changes

SHW has been the subject of several analyst reports. Wells Fargo & Company set a $410.00 target price on Sherwin-Williams and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. UBS Group restated a “buy” rating and issued a $422.00 price target (up previously from $400.00) on shares of Sherwin-Williams in a report on Wednesday, October 29th. Bank of America dropped their price objective on shares of Sherwin-Williams from $375.00 to $368.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 14th. Royal Bank Of Canada set a $405.00 target price on shares of Sherwin-Williams and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Finally, Loop Capital lowered their price target on shares of Sherwin-Williams from $395.00 to $380.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $390.87.

Get Our Latest Analysis on Sherwin-Williams

Insider Activity

In related news, insider Justin T. Binns sold 609 shares of the company’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $368.82, for a total transaction of $224,611.38. Following the completion of the transaction, the insider directly owned 17,922 shares in the company, valued at $6,609,992.04. This represents a 3.29% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.60% of the company’s stock.

Sherwin-Williams Profile

(Free Report)

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.

Recommended Stories

Institutional Ownership by Quarter for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.